China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2025)

China Pharma Holdings (CPHI) reported Change in Intangibles of $5313.0 for Q4 2025, down 86.71% quarter-over-quarter from $39987.0 in Q3 2025.

China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2025) Analysis & Trends

China Pharma Holdings has reported Change in Intangibles for 6 years, with the latest figure at $5313.0 in Q4 2025.

For the quarter ending Q4 2025, Change in Intangibles changed N/A year-over-year to $5313.0; the trailing twelve-month figure through Dec 2025 stood at $77927.0 (changed N/A YoY), and the FY2025 full-year result was $77927.0, down 69.24% from the prior year.
Change in Intangibles for Q4 2025 stood at $5313.0, down from $39987.0 in the prior quarter.
The five-year high for Change in Intangibles was $39987.0 in Q3 2025, with the low at $5313.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	China Pharma Holdings	18.87 Mn	18.70 Mn	285,487.00	-

Download Data